Terms: = Prostate cancer AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18 AND Diagnosis
4 results:
1. GOLM1 Promotes Epithelial-Mesenchymal Transition by Activating TGFβ1/smad2 Signaling in prostate cancer.
Qin X; Liu L; Li Y; Luo H; Chen H; Weng X
Technol Cancer Res Treat; 2023; 22():15330338231153618. PubMed ID: 36999196
[No Abstract] [Full Text] [Related]
2. miR-188-5p inhibits proliferation, migration, and invasion in gallbladder carcinoma by targeting Wnt2b and smad2.
Li XL; Li SZ; Wu CX; Xing XH
Kaohsiung J Med Sci; 2021 Apr; 37(4):294-304. PubMed ID: 33236530
[TBL] [Abstract] [Full Text] [Related]
3. prostate cancer in Men With Treated Advanced Heart Failure: Should we Keep Screening?
Lee HH; Shaw NM; Mohammed S; Kowalczyk KJ; Stamatakis L; Krasnow RE
Urology; 2020 Feb; 136():46-50. PubMed ID: 31786304
[TBL] [Abstract] [Full Text] [Related]
4. prostate cancer incidence and newly diagnosed patient profile in Spain in 2010.
Cózar JM; Miñana B; Gómez-Veiga F; Rodríguez-Antolín A; Villavicencio H; ; Cantalapiedra A; Pedrosa E
BJU Int; 2012 Dec; 110(11 Pt B):E701-6. PubMed ID: 22989066
[TBL] [Abstract] [Full Text] [Related]
